Zhu, et al., “Cloning of a New Member of the Peroxisome Proliferator-activated Receptor Gene . . . ”, J. of Biol. Chem., vol. 268, No. 36, pp. 26817-26820, Dec. 25, 1993. |
Greene, et al., “Isolation of the Human Peroxisome Proliferator Activated Receptor Gamma cDNA: Expression . . . ”, Gene Expression, vol. 4, pp. 281-2999, 1993. |
Tontonoz, et al., “Stimulation of Adipogenesis in Fibroblasts by PPARy2, a Lipid-Activated Transcription Factor”, Cell, vol. 79, pp. 1147-1156, Dec. 30, 1994. |
Forman, et al., “15-Deoxy— 12,14-Prostaglandin J2 is a Ligand for the Adipocyte Determination Factor PPARy”, Cell, vol. 83, pp. 803-812, Dec. 1, 1995. |
Kliewer, et al., “A Prostaglandin J2 Metabolite Binds Peroxisome Proliferator-Activated Receptor y and Promotes . . . ”, Cell, vol. 83, pp. 813-819, Dec. 1, 1995. |
Lehmann, et al., “An Antidiabetic Thiazolidinedione is a High Affinity Ligand for Peroxisome Proliferator . . . ”, J. of Biol. Chem., vol. 270, No. 22, pp. 12953-12956, Jun. 2, 1995. |
Elbrecht, et al., “Molecular Cloning, Expression and Characterization of Human Peroxisome Proliferator . . . ”, Biochem. and Biophys. Res. Comm., vol. 224, pp. 431-437, 1996. |
Santoro, et al., “PGJ2, A New Antiviral Prostaglandin: Inhibition of Sendai Virus Replication and Alteration . . . ”, J. Gen. Virol., vol. 68, pp. 1153-1158, 1987. |
Dreyer, et al., “Control of the Peroxisomal B-Oxidation Pathway by a Novel Family of Nuclear Hormone Receptors”, Cell, vol. 68, pp. 879-887, Mar. 6, 1992. |
Chen, et al., “Identification of Two mPPAR Related Receptors and Evidence for the Existence . . . ”, Biochem. and Biophys. Res. Comm., vol. 196, No. 2, pp. 671-677, Oct. 29, 1993. |
Kliewer, et al., “Differential expression and activation of a family of murine peroxisome proliferator . . . ”, Proc. Natl. Acad. Sci. USA, vol. 91, pp. 7355-7359, Jul. 1994. |
Tontonoz, et al., “mPPARy: tissue-specific regulator of an adipocyte enhancer”, Genes & Development, vol. 8, pp. 1224-1234, 1994. |
Zhu, et al., “Structural organization of mouse peroxisome proliferator-activated receptor y (mPPARy) gene . . .”, Proc. Natl. Adac. Sci. USA, vol. 92, pp. 7921-7925, Aug. 1995. |
Aperlo, et al., “cDNA cloning and characterization of the transcriptional activties of the hamster peroxisome . . . ”, Gene, vol. 162, pp. 297-302, 1995. |
Duvic et al 111CA:225334, 1988.* |
Hughes-Fulford, et al., “Inhibition of DNA Synthesis and Cell Cycle by Prostaglandins Independent of Cyclic AMP”, Advances in Prostaglandin, Thromboxanee and Leukotriene Research, vol. 15, pp. 401-404, 1985. |
Lacal, et al., “Effects of Cyclopentenone Prostaglandins on Myeloid Cells during Early Infection with HTLV-1.II. Regulation of Synthesis of Inducible p72 Heat Shock Protein”, Journal of Pharmacology and Experimental Therapeutics, vol. 271, No. 2, pp. 10096-1102, 1994. |
Mueller, et al., “Terminal Differentiation of Human Breast Cancer through PPARγ”, Molecular Cell, vol. 1, pp. 465-470, Feb. 1998. |
Narumiya, et al., “Site and Mechanism of Growth Inhibition by Prostaglandins. I. Active Transport and Intracellular Accumulation of Cyclopentenone Prostaglandins . . . ”, Journal of Pharmacol. and Exp. Therap., vol. 239, No. 2, pp. 500-505, 1986. |
Narumiya, et al., “Site and Mechanism of Growth Inhibition by Prostaglandins. II. Temperature-Dependent Transfer of a Cyclopentenone Prostaglandin to Nuclei”, Journal of Pharmacol. and Exp Therap., vol. 239, No. 2, pp. 506-511, 1986. |
Rozera, et al., “Inhibition of HIV-1 Replication by Cyclopentenone Prostaglandins in Acutely Infected Human Cells”, J. Clin. Invest., vol. 97, No. 8, Apr. 1996, pp. 1795-1803. |
Santoro, et al., “Involvement of Protein Synthesis in the Antiproliferative and the Antiviral Action of Prostaglandins”, Prostaglandins in Cancer Research, pp. 97-114. |
Santoro, et al., “PGJ2, A New Antiviral Prostaglandin: Inhibition of Sendai Virus Replication and Alteration of Virus Protein Synthesis”, J. Gen. Virol., vol. 68, pp. 1153-1158, 1987. |
Sasaki, et al., “Prostaglandins in the treatment of cancer”, Anti-Cancer Drugs, vol. 5, pp. 131-138, 1994. |
Xing, et al., “Rat PPARδ Contains A CGG Triplet Repeat and Is Prominently Expressed in the ThalamicNuclei”, Biochem. and Biophys. Res. Comm., vol. 217, No. 3, 1995, pp. 1015-1025. |